Skip to main content
Clinical Trials/CTRI/2024/07/070645
CTRI/2024/07/070645Not yet recruitingPhase 3

A Pharmacotherapeutic controlled study to evaluate the Efficacy of Shweta Aparajita root Clitoria ternatea Linn. in Arka dosage form as add on along with Thyroxine in the management of Galganda i.e. Primary Hypothyroidism. - NI

Dr Jayshree Hadke0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients between the age group of 25-50 years & of any Gender.
  • Patients who are already diagnosed as Primary Hypothyroidism and under Thyroxine
  • medication and within six months of Diagnosis and newly diagnosed cases.
  • Patients who are willing and sign the informed consent form.

Exclusion Criteria

  • Patient suffering from systemic disease like Cardiac Disorder/Diabetes
  • Mellitus/COPD/TB/HIV/HCV/HBsAg
  • Immuno-compromised patients.
  • Pregnancy and lactating mother and Renal insufficiency.
  • Patient who are known case of Congenital Hypothyroidism, Hypopitutarism, Secondary
  • Hypothyroidism, Thyroid, Neoplasia & Progressive cases of Myxedema coma.
  • Any serious medical and psychological condition will be excluded.
  • Malabsorption disorders
  • Concomitant use of drugs such as multivitamins, minerals, phenobarbital, phenytoin,
  • carbamazepine, rifampin, glucocorticoids, warfarin, statins, estrogen, and raloxifene.

Investigators

Sponsor
Dr Jayshree Hadke

Similar Trials